Effect of interferon respiratory infections of animals.
Several animal models are available for the evaluation of interferon in respiratory virus infections. Considerable variability exists among the respiratory viruses with respect to sensitivity to exogenous interferon or induced endogenous interferon. Due to this apparent variability, combinations of interferon with immune serum and chemotherapeutic agents may provide a means of more efficient control of respiratory infections.
D000818:Animals; D002417:Cattle; D006566:Herpesviridae Infections / Q000188:drug therapy; D007241:Infectious Bovine Rhinotracheitis / Q000188:drug therapy; D007369:Interferon Inducers / Q000494:pharmacology; D007372:Interferons / Q000096:biosynthesis / Q000494:pharmacology*; D009976:Orthomyxoviridae Infections / Q000188:drug therapy; D018184:Paramyxoviridae Infections / Q000188:drug therapy; D011024:Pneumonia, Viral / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000378:metabolism; D014777:Virus Diseases / Q000188:drug therapy* / Q000378:metabolism
D007369:Interferon Inducers; D007372:Interferons